secretory leukocyte peptidase inhibitor

分泌型白血球ペプチダーゼ阻害物質、分泌型白血球ペプチダーゼインヒビター

関

SLPI

WordNet

1. limit, block, or decrease the action or function of; "inhibit the action of the enzyme"; "inhibit the rate of a chemical reaction"
2. control and refrain from showing; of emotions, desires, impulses, or behavior (同)bottle up, suppress
3. limit the range or extent of; "Contact between the young was inhibited by strict social customs"
4. a substance that retards or stops an activity
5. blood cells that engulf and digest bacteria and fungi; an important part of the bodys defense system (同)leucocyte, white_blood_cell, white_cell, white blood corpuscle, white_corpuscle, WBC
6. of or relating to or producing a secretion; " a secretory cell"

PrepTutorEJDIC

1. 〈感情・欲望・行動・作用など〉‘を'抑制する / (…しないように)〈人〉‘を'抑制する,妨げる《+『名』+『from』+『名』(do『ing』)》
2. 抑制する人(物) / 化学反応抑制剤

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. ACE 阻害薬誘発性血管浮腫 ace inhibitor induced angioedema
• 2. 炎症の病因における白血球内皮細胞接着 leukocyte endothelial adhesion in the pathogenesis of inflammation
• 3. 白血球粘着不全症 leukocyte adhesion deficiency
• 4. 2型糖尿病の治療のためのジペプチジルペプチダーゼ4（DPP-4）阻害剤 dipeptidyl peptidase 4 dpp 4 inhibitors for the treatment of type 2 diabetes mellitus
• 5. 後天性C1インヒビター欠損症：管理および予後 acquired c1 inhibitor deficiency management and prognosis

English Journal

• Cervical Expression of Elafin and SLPI in Pregnancy and Their Association With Preterm Labor.

• Itaoka N1, Nagamatsu T1, Schust DJ2, Ichikawa M1, Sayama S1, Iwasawa-Kawai Y1, Kawana K1, Yamashita T1, Osuga Y1, Fujii T1.
• American journal of reproductive immunology (New York, N.Y. : 1989).Am J Reprod Immunol.2015 Jun;73(6):536-44. doi: 10.1111/aji.12354. Epub 2015 Jan 5.
• PROBLEM: Elafin and secretory leukocyte peptidase inhibitor (SLPI) are unique among antimicrobial peptides (AMPs). This study aimed to determine the expression levels of these AMPs at the cervix during pregnancy and to investigate their association with preterm labor.METHOD OF STUDY: Cervical epithe
• PMID 25559229

• Antimicrobial Peptide LL-37 Is Both a Substrate of Cathepsins S and K and a Selective Inhibitor of Cathepsin L.

• Andrault PM1, Samsonov SA2, Weber G3, Coquet L4, Nazmi K5, Bolscher JG5, Lalmanach AC6, Jouenne T4, Brömme D7, Pisabarro MT2, Lalmanach G1, Lecaille F1.
• Biochemistry.Biochemistry.2015 May 5;54(17):2785-98. doi: 10.1021/acs.biochem.5b00231. Epub 2015 Apr 27.
• Lung cysteine cathepsins B, K, L, and S contribute to physiological and pathological processes including degradation of antimicrobial peptides/proteins (AMPs) such as surfactant protein SP-A, lactoferrin, secretory leukocyte peptidase inhibitor, and beta-defensins-2 and -3. Substantial amounts of un
• PMID 25884905

• Using next-generation RNA sequencing to examine ischemic changes induced by cold blood cardioplegia on the human left ventricular myocardium transcriptome.

• Muehlschlegel JD1, Christodoulou DC, McKean D, Gorham J, Mazaika E, Heydarpour M, Lee G, DePalma SR, Perry TE, Fox AA, Shernan SK, Seidman CE, Aranki SF, Seidman JG, Body SC.
• Anesthesiology.Anesthesiology.2015 Mar;122(3):537-50. doi: 10.1097/ALN.0000000000000582.
• BACKGROUND: The exact mechanisms that underlie the pathological processes of myocardial ischemia in humans are unclear. Cardiopulmonary bypass with cardioplegic arrest allows the authors to examine the whole transcriptional profile of human left ventricular myocardium at baseline and after exposure
• PMID 25581909

Japanese Journal

• MyD88 Deficiency Alters Expression of Antimicrobial Factors in Mouse Salivary Glands

• PLOS one 9(11), e113333, 2014-11-21
• NAID 120005540298

• Secretory leukocyte peptidase inhibitor and lung cancer

• Cancer science 99(5), 849-855, 2008-05-10
• NAID 10024005504

Related Links

• Secretory leukocyte peptidase inhibitor and lung cancer.

1. Cancer Sci. 2008 May;99(5):849-55. doi: 10.1111/j.1349-7006.2008.00772.x. Secretory leukocyte peptidase inhibitor and lung cancer. Nukiwa T(1), Suzuki T, Fukuhara T, Kikuchi T. Author information: (1)Department of ...

• Secretory leukocyte protease inhibitor: a pivotal mediator of ...

1. Hepatology. 2014 Apr;59(4):1564-76. doi: 10.1002/hep.26933. Epub 2014 Feb 28. Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure. Antoniades CG ...

---

★リンクテーブル★

リンク元	「分泌型白血球ペプチダーゼ阻害物質」「分泌型白血球ペプチダーゼインヒビター」
関連記事	「inhibit」「inhibitor」「peptidase」「peptidase inhibitor」「secretory」

「分泌型白血球ペプチダーゼ阻害物質」

　　[★]

英

secretory leukocyte peptidase inhibitor、SLPI

関

分泌型白血球ペプチダーゼインヒビター

「分泌型白血球ペプチダーゼインヒビター」

　　[★]

英

secretory leukocyte peptidase inhibitor

関

分泌型白血球ペプチダーゼ阻害物質

「inhibit」

　　[★]

• v.

• 抑制する、阻害する、阻止する

関

abrogate、block、depress、depression、deter、inhibition、interdict、prevent、prevention、repress、repression、restrain、restraint、suppress、suppression

　 　 　 　

「inhibitor」

　　[★]

• n.

• 阻害剤、阻害薬、抑制薬、抑制剤、(内在性物質について)インヒビター、抑制物質

関

blocker、depressant、suppressant

　 　

「peptidase」

　　[★]

ペプチダーゼ、ペプチド加水分解酵素

関

peptide hydrolase、protease、proteinase、proteolytic enzyme

「peptidase inhibitor」

　　[★]

• ペプチダーゼ阻害薬、ペプチダーゼ阻害剤

関

antiprotease、protease inhibitor

「secretory」

　　[★]

• adj.

• 分泌性の、分泌型の